Cord Blood Transplantation Study (COBLT): Cord Blood Bank Standard Operating Procedures. J Hematother, 7, 521-561. presented at the 1998.. (1998).
Review of the COBLT Study Processing Procedures. presented at the 2000.. (2000).
Search Process. presented at the 2000.. (2000).
Characteristics of cord blood collections: the COBLT Study cord blood bank experience. presented at the 2001.. (2001).
Cord blood donor pre-screening: Impact of exclusion criteria on minority recruitment. presented at the 2001.. (2001).
Characterization of Banked Umbilical Cord Blood Hematopoietic Progenitor Cells (HPC) and Lymphocyte Subsets (LS) and Correlation with Ethnicity, Birth Weight, Gender and Type of Delivery: A COBLT Study Report. Transfusion, 45, 856-866. presented at the 06/2005. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/15934982. (2005).
Results of the Cord Blood Transplantation Study (COBLT) Unrelated Donor Banking Program. Transfusion, 45, 842-855. presented at the 06/2005. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/15934981. (2005).
Umbilical Cord Blood Transplantation in Pediatric Patients with Malignant Diseases: Results of a Prospective, Multi-Institutional NHLBI Sponsored Trial. In 2005 ASBMT Tandem BMT Meetings. presented at the 10/02/2005, Keystone, CO.. (2005).
Alternative Donor Transplantation: Results of Parallel Phase II Trials Using HLA-Mismatched Related Bone Marrow or Unrelated Umbilical Cord Blood Grafts. Blood, 118, 282-288. presented at the 07/2011. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/21527516. (2011).
Fludarabine-Based Conditioning for Marrow Transplantation From Unrelated Donors in Severe Aplastic Anemia: Early Results of a Cyclophosphamide Dose De-Escalation Study Show Life-Threatening Adverse Events at Predefined Cyclophosphamide Dose Levels. Biol Blood Marrow Transplant, 18, 1007-1011. presented at the 07/2012. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/22546497. (2012).
Lack of Enhanced Survival after Double Umbilical Cord Blood (UCB) Transplant Compared to Single UCB Transplant in Children with Hematological Malignancy: Results of the BMT-CTN Randomized Trial. In 54th Annual ASH Meeting. presented at the 08/12/2012, Atlanta, GA. Retrieved from http://www.hematology.org/Meetings/Annual-Meeting/. (2012).
Phase 3 Clinical trial of Steroids/Mycophenolate Mofetil vs Steroids/Placebo as Therapy for Acute GVHD: BMT CTN 0802. Blood, 124, 3221-3227. presented at the 11/2014. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/25170121. (2014).
Randomized, Double-Blind, Placebo-Controlled Trial of Soluble Tumor Necrosis Factor Receptor: Enbrel (Etanercept) for the Treatment of Idiopathic Pneumonia Syndrome After Allogeneic Stem Cell Transplantation: BMT CTN Protocol. Biol Blood Marrow Transplant, 20, 858-864. presented at the 06/2014. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/24607553. (2014).
Tacrolimus/Sirolimus vs Tacrolimus/Methotrexate as GVHD Prophylaxis After Matched, Related Donor Allogeneic HCT. Blood, 124, 1372-1377. presented at the 08/2014. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/24982504. (2014).